No Data
No Data
Daga Weikang: 2024 Semi-Annual Report Summary
Daga Weikang: 2024 Semi-Annual Report
Dajia Vicom (301126.SZ): net income for the first half of the year was 31.834 million yuan, a year-on-year increase of 75.04%.
On August 29th, Ge Long Hui reported its semi-annual report for 2024, with operating revenue of 2.6 billion yuan, a year-on-year growth of 46.95%; net profit attributable to shareholders of the listed company of 31.834 million yuan, a year-on-year growth of 75.04%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses of 31.1106 million yuan, a year-on-year growth of 90.32%; and basic earnings per share of 0.15 yuan.
Vicom Ltd (301126.SZ) released its first-half financial performance, with a net income of 31.834 million yuan, a growth of 75.04%.
Vicom Ltd (301126.SZ) released its 2024 interim report, with a revenue of 2.6 billion yuan, ...
Vicom Ltd. (301126.SZ): Jiachen Hospital has established an Assisted Reproduction (IVF) Center, setting up embryo culture room, semen processing room, transplantation surgery room and embryo freezing room.
On August 14th, Gelunhui reported that Vicom Ltd. (301126.SZ) stated on the investor interactive platform that Jia Chen Hospital, which is owned by the company, is applying for a review of a third-level specialized hospital. Due to the high barriers of assisted reproductive technology, the license application process is lengthy, and the approval criteria are strict, there is uncertainty about the prospects for the company to continue to carry out assisted reproduction business. Jia Chen Hospital has established an assisted reproduction (IVF) center and established embryo culture rooms, sperm processing rooms, transplantation operating rooms, and embryo freezing rooms. Currently, the hospital is making further preparations and construction in accordance with the requirements of "human assisted reproductive technology specifications." After obtaining the qualification of human assisted reproductive licensing, the hospital will begin its operations.
Vicom Ltd (301126.SZ) has repurchased 0.43% of its shares.
On August 1st, Glon Hui announced that until July 31, 2024, Vicom Ltd (301126.SZ) had repurchased 892,300 shares of the company through a share repurchase special securities account by means of centralized bidding trading, accounting for 0.43% of the company's current total share capital. The highest fill price was 9.76 yuan/share, the lowest fill price was 8.77 yuan/share, and the total amount of funds used was 8,118,966.00 yuan (excluding transaction commission and other fees). This buyback meets the requirements of the company's buyback plan and relevant laws and regulations.
No Data
No Data